There's a lot happening in Canada when it comes to pharmaceutical logistics. From evolving regulations to drug shortages to new, technological advancements, the industry is poised for significant disruption and growth.

With this in mind, we asked our audience, "what are your top strategic priorities going into 2020?". DOWNLOAD our latest infographic to find out what they told us and gain an overview of:

• Where the industry is investing when it comes to cold chain solutions
• The top challenges the industry is currently facing
• What the future holds for Canada's Cold Chain community

This in-depth, 15 page report takes a deep dive into:

• The latest Health Canada regulatory updates

• How Canada's cold chain leaders are combating drug shortages

• Cutting-edge last mile delivery innovations & solutions

Canada's life sciences temperature controlled supply chain has never been riper for disruption. In between evolving regulations and the emergence of game-changing technology such as AI and autonomous, the industry is poised for unprecedented change in 2020 and over the next decade. Download this special report to learn more about:

• GUI-0069 guidelines and projected 2020 updates
• Changes to the guidance on drug establishment licenses and associated fees
• 2020 GMP changes
• Licensing for atypical active pharmaceutical ingredients
• How AI and supply chain analytics are transforming the way biopharma firms confront drug shortages
• The current state of and the road ahead for autonomous trucking, real-time temperature control monitoring and AI-powered drone delivery

Access the Early Event Info Flyer to see what we have in store for you this year, including:

• EARLY-CONFIRMED SPEAKERS: CXOs, VPs, and Directors of Supply Chain, Quality Assurance, Blockchain and Regulatory Affairs. 
• KEY THEMES FOR 2020: honing in on obstacles in drug development, drug supply, extreme temperatures, logistical inefficiencies, digitization, patient centricity, and new regulations. 
• NEW EARLY-CONFIRMED SITE TOURS: limited to 25 attendees each; don't miss out!

Interested in attending the 2020 Cold Chain Global Forum Canada? Don't forget to do your due diligence first! Download our past attendee snapshot to get a preview of who you can expect to meet and learn from this year! Top job titles include VPs, Directors and Heads of:

• Cold Chain
• Temperature Control Supply Chain
• Distribution
• Transportation 
• QA / QC
• Packaging

Presentation by Kimby Barton, Director of the Health Product and Licensing Division (HPIL), Health Products Compliance Directorate Health Canada’s Regulatory Operations and Regions Branch

• What we are seeing in terms of compliance and areas for improvement
• Performance statistics
• Upcoming guidance documents for consultation
• International collaboration and harmonization
• New regulatory packages and implications for industry

The National Cyber Forensics and Training Alliance (NCFTA) was established in 2002 as a non-profit partnership between private industry, government and academia to provide a neutral, trusted environment that enables a two way collaboration and cooperation to identify, mitigate an disrupt cyber crime. 

1. View NCFTA research on the online availability of pharmaceuticals including cold chain products on domains and trade sites, highlighting alleged available “stealth” or “discreet” shipping and the potential delays in shipments that could affect the integrity of the supply chain
2. Describe the potential risks and implications posed by cybercriminals to the supply chain as well as provide an overview on threats posed by zerodays, malware, IoT vulnerabilities and other system issues that could affect the logistics and transactional steps involved
3. Include how to follow transactions, evaluate vendor profiles, the challenges posed tracking cryptos, and a review of the use of the dark web by criminals

Presentation by:

• Cliff Riggs, Intelligence Analyst III, The National Cyber Forensics and Training Alliance (NCFTA)
• Stephanie Walker, Intelligence Analyst, The National Cyber Forensics and Training Alliance (NCFTA)

The notion of the “Supply Chain 4.0” proposes a plethora of new digital solutions for the pharma market to adopt including EWM, Cost Design, Integrated Business Planning, Web Barcodes, IOT, Blockchain, AI, and Cloud-based Solutions to optimize the supply chain. With all of the new technology for integration, it is imperative to become more digitized. What can we do in the Canadian Market to become more integrated in the digital world?

• What is the Industry 4.0 and will it remain a game changer for the entire supply chain?
• How close are we to the Digital Supply Chain?
• Discussing processes for digitalization transformation
• Integration of the end –to- end Canadian supply chain Practical Module:
• How can we integrate the supplier through to the customer in an truly networked supply chain?

Presentation by Dave Malenfant, Director, Center for Supply Chain Innovation, Texas Christian University

Presentation by Shital Parik Mars, Chief Executive Officer, Progressive Care

Shital Mars is the Chief Executive Officer of Progressive Care, a personalized healthcare services and technology company. Under her direction, Shital has guided Progressive Care and its wholly-owned subsidiary PharmCo LLC on a rapid growth trajectory with the signing of an investment deal with The Benchmark Company in June 2018 and the acquisition of Touchpoint pharmacy. 

• Creating and implementing systems that help improve patient adherence and provide risk management practices for physicians and providers.
• Applying digital technologies to gain increased visibility into supply chain operations and make better and faster decisions
• Combatting the nationwide opioid epidemic through a campaign designed to educate patients, physicians and providers on pain management alternatives

• With new and emerging technologies how will or can this change the way we qualify routes and or validate shippers?
• Do we foresee how regulations may change as new and emerging technologies are implemented throughout or supply chains?
• How can new and enhanced temperature data monitors better serve manufacturer-to-patient supply chain controls?
• How is drone technology best used in different regions?

Presentation by Nedal Ismail, Professor and Program Coordinator, Bachelor of Commerce, Supply Chain Management &Management Studies, The Business School, Humber Institute of Technology & Advanced Learning

With regulators across the globe becoming increasingly interested in how organizations are controlling the variables when distributing CRT/Ambient products, companies must re-assess their processes to ensure compliance. Even if total temperature monitoring is not required by regulators, it is crucial to show that you have strong processes in place to stay off their radar. Regulators want to see that you have your documentation in order for these products and have a full understanding of your transport process.

• Calculate accurate temperature profiles for ambient products and properly analyze data collected
• Understand the environment where your products will be traveling and how to best control the elements
• Define your routes through qualification & validation of shipping lanes and profiling using historical data
• Pinpoint the packaging required to seamlessly ship ambient products globally and where a more custom design is needed
• Discuss the global GDP landscape for CRT products and where your products get flagged more often

Presentation by M. Dave Malenfant, Director, Outreach & Partnerships, Center for Supply Chain Innovation, Neeley School of Business 

Join Claude Jolicoeur, Director of Regulatory Affairs, McKesson Canada Corp as he discusses topics that include; changes within the supply chain industry on capturing and sharing data, real time temp monitoring technologies & cold chain challenges within the Canadian market.

Join Andrea L. Guisbert-Williams, Project Manager, North American Logistics Operations, Eli Lilly & Company in an exclusive interview about the effect of growth of biologic based products on temp controlled operations, next generation medicines, and her case study, Discovering Eli Lilly’s Plan to Achieve Cost Savings & Sustainability Through a Switch from Air to Ocean.

Join Gilles Jr. Gregoire, Global Transport Manager, Pharmascience as he discusses topics that include; the 3 biggest temperature controlled packaging trends, real time temp monitoring technologies, the growing trend towards “direct to patient” deliveries and much more.

We sat down and spoke with with Rey Chern, Director, Engineering, Amgen; Lisa Sykes, Director of Quality Operations and Sterile Network, Merck; Bernard McGarvey, Senior Engineering Advisor, Eli Lilly and Company; Dan Mirica, Former Head of Global Logistics, Lonza Biologics; & Henrik Fröjdh, Associate Director Supply Chain Management, Merck & Co. on:

• Temperature-controlled industry
• The biggest disruptive technologies
• Collaboration within the industry

Email enquiry@iqpc.com to request the video link sent to you via email.

Cold chains in Canada need to be especially robust due to the region’s vast territories, extreme temperatures and formidable regulatory processes amongst other potential complications. In this highlights video, we summarize our in-depth report on Distributing Medicines in Canada and showcase how pharmaceutical supply chain leaders overcome the challenges associated with:

• Transporting drugs over immense, desolate geography
• Managing import/export operations and customs control
• Ensuring quality control over a wide-range of temperatures
• Working with global, external partners

Find out exactly what to expect at Cold Chain Global Forum Canada in our event highlight video. Get a taste of all the experiences CCGF Canada provides and take a look at the largest temperature controlled life science supply chain event in Canada.

• Collaboration with carriers to keep temperatures within source conditions
• Challenges with the last mile & saving cost in quality investments
• Needs from data logging and RFID technology
  
  

Email enquiry@iqpc.com to request an emailed copy of the video.

We sat down with Dan Mirica, Former Head of Logistics, Lonza Biologics and discussed: 

• blockchain applications for the pharma supply chain
• challenges with drone implementation
• the emergence of self driving trucks in Europe
  

How to build on-the-ground excellence and protect critical business functions

This whitepaper explores:

• The growing need for business continuity planning
• Understanding the risk landscape
• Protecting critical functions and processes
• Ensuring on-the-ground operational engagement
• Adopting a mitigation mindset
• Business continuity planning in practice

With a rise in precision medicines, high value shipments and emergingshipping routes, global biopharma industry spending on temperaturecontrolled products is expected to reach $15.7 billion in 2019.1 To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialized and trusted partners.

In this report, Pharma IQ explores how these trends will affect temperature control and logistics spending in the next 12 to 24 months. All the findings from our recent survey are presented and analysed below.

Across the pharmaceutical supply chain, losses associated with temperature lapses are estimated to be worth £320bn globally.[1] To ensure the profitability of the pharmaceutical industry and patient safety, supply chains must limit the risk of damage to products.

Warehouses are a critical area of risk due to the hectic pace of operations and potential for errors in judgment or processes by workers. To ensure the safe storage and continuity of supply for pharmaceutical products, supply chain leaders must operate with smart warehouse management in mind.

In this report, we cover five areas where a company can improve warehouse operations:

• Smart warehouse management is integral to the efficient running of pharmaceutical supply chains
• Carefully weighing up the benefits and risks of a centralised or decentralised warehouse strategy
• Deciding when and where to use warehouse automation and technology
• Managing critical risk points in warehouse operations
• Ensuring a flexible warehousing strategy to meet market changes
• Integrating last mile distribution into warehousing

From the proliferation of IoT to the rise of artificial intelligence, 2020 is poised to be a BIG year for the pharmaceutical supply chain both within Canada and beyond. We invite you to read our latest report on the top temperature-controlled pharmaceutical logistics trends and what they mean for you. Plus! See results from our 2019 attendee survey to see how you compare to your peers when it comes to supply chain maturity, strategic priorities & budgets. 

A guidebook for the year ahead, DOWNLOAD to read the latest facts, figures & expert insights related to:

• 2020 Industry Stats
• Global Regulatory Updates: new DSCSA deadlines, Pilot Program highlights & global regulatory reform 
• Blockchain in Brief: an overview of emerging blockchain applications and how they're maximizing cold chain security as well as efficiency 
• Real-Time Tracking & Analytics: embracing visibility, accountability & data-driven decision making
• New Avenues of Cost Control: using cutting-edge technology such as AI and machine learning to identify and exploit untapped savings throughout the pharma supply chain
• Last Mile Delivery 4.0: exploring the temperature-controlled controlled supply chain in the age of drones, autonomous vehicles and customer-centricity